Eileen Scigliano, MD

Clinical Focus

• Acute Lymphoid Leukemia
• Acute Myeloid Leukemia
• Adult Non-Hodgkin's Lymphoma
• Bone Marrow Transplantation
• Bone Marrow Transplantation, Allogeneic
• Bone Marrow Transplantation, Autologous
• Hematologic Malignancies
• Hematology
• Hodgkin's Disease

Show More

• Acute Lymphoid Leukemia
• Acute Myeloid Leukemia
• Adult Non-Hodgkin's Lymphoma
• Bone Marrow Transplantation
• Bone Marrow Transplantation, Allogeneic
• Bone Marrow Transplantation, Autologous
• Hematologic Malignancies
• Hematology
• Hodgkin's Disease
• Hodgkin's Lymphoma
• Leukemia
• Lymphoma
• Mantle Cell Lymphoma
• Multiple Myeloma
• Myelodysplastic Syndromes
• Myelofibrosis
• Myeloproliferative Disorders
• Plasma Cell Neoplasms
• Primary Central Nervous System Lymphoma
• Waldenström's Macroglobulinemia

Insurance Information

Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).

Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.

Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.

Publications

Article:33

Review Article:1

Letter:4

Chapter:1

Recent Artifacts

• Patient-generated strategies for strengthening adherence to multiple medication regimens after allogeneic stem cell transplantation: a qualitative study
• Central Nervous System Hemophagocytic Lymphohistiocytosis (CNS-HLH) from Leptomeningeal Anaplastic Large Cell Lymphoma: Mild Clinical Neurologic Syndrome with Extensive Multifocal White Matter Disease
• Long-term Outcomes of team-based learning
• It Takes a Team to Make It Through: The Role of Social Support for Survival and Self-Care After Allogeneic Hematopoietic Stem Cell Transplant
• Hemolysis and Hemoglobin Structure and Function: A Team-Based Learning Exercise for a Medical School Hematology Course
• Prevalence of Cytopenia in the General Population—A National Health and Nutrition Examination Survey Analysis
• A case of syngeneic graft-versus-host disease
• Stem cell transplantation for lymphoproliferative disorders
• Lymph nodes can accurately be measured on PET-CT for lymphoma staging/restaging without a concomitant contrast enhanced CT scan
• Systematic light exposure in the treatment of cancer-related fatigue: A preliminary study

Industry Relationships

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.

Below are financial relationships with industry reported by Dr. Scigliano during 2022 and/or 2023. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.